Navigation Links
Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
Date:9/23/2010

93

Amicus could provide competition in the long term 94

Genitourinary 95

Renagel/Renvela 95

Overview 96

Sales forecast 97

Therapeutic diversification through M&A 97

Established product 97

Strong sales force and good safety... 97

...backed by the NKF 97

Competition does exist 98

Renvela developed in order to consolidate Genzyme's position as number one 98

Label expansion into CKD patients not on dialysis 98

Hectorol 99

Overview 99

Sales forecast 100

Product gained through acquisition 100

Used as a complimentary product 100

Competition from Amgen 100

Oncology 101

Mozobil 101

Overview 101

Sales forecast 102

Innovative therapy supporting Genzyme's exploration into oncology 102

Strong clinical trial data 102

Clolar 104

Overview 104

Sales forecast 105

Acquisition of Bioenvision provided Clolar and boosted Genzyme's oncology offering 105

While approval in AML will significantly broaden Clolar's label, increased economic constraints on healthcare systems may restrict its uptake 105

Price and further competition will impede growth 105

Central nervous system 107

Campath 107

Overview 107

Sales forecast 108

Phase II data show superior efficacy compared to Rebif 108

Safety concerns 109

Future market potential 109

Chapter 8 Appendix 111

R&D pipeline 111

References 112

Datamonitor reports 112

Abbreviations 112

About Datamonitor 114

About Datamonitor Healthcare 114

Datamonitor consulting 114

Disclaimer 116

List of Tables Table 1: Genzyme - PharmaVitae forecasts at a glance 9

Table 2: Genzyme quarterly sales ($m), Q408-Q409 24

Table 3: Genzyme future product milestones, 2010-12 31

Table 4: Genzyme's acquisition history (2000-200
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by AstraZeneca plc, quetiapine ... important drug for the treatment of schizophrenia. Approved ... was listed in the Catalogue of Drugs for ...
(Date:8/28/2015)... 28, 2015 The scientific team of ... one of the leading academics in the field of aging ... holder in life extension for model animals - 10 fold ... aging and age-related diseases, primarily, around the stability and stress ... been published as "Stability analysis of a model gene network ...
(Date:8/28/2015)... and ATLANTA , August 28, 2015 ... Food and Drug Administration (FDA) cleared the MagVita TMS Therapy ... patients who have failed to receive satisfactory improvement from prior ... technique for stimulating neural tissue in the part of the ... procedure has been proven safe and effective and MagVenture is ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... Colo., Oct. 17 Pharmion Corporation,(Nasdaq: PHRM ... pivotal,Phase 3 clinical trial evaluating amrubicin, the Company,s ... cell lung,cancer (SCLC). The randomized, controlled, multi-center study ... for second-line,treatment of SCLC in the US and ...
... and Bare ... Metal Stents, ... Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R stent has reached 110 ... de Winter, M.D., Ph.D.,principal investigator and director of the catheterization laboratory ...
Cached Medicine Technology:Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 2Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 3Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 4Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 5Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket ... zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. ... SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. ... whitening. For just $199, patients can currently receive a one hour treatment of this ... procedures, but it includes a number of unique features that can turn teeth up ...
(Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to receive orphan drug ... use any time soon, according to educational website Surviving Mesothelioma. Click here to ... drug designation for mesothelioma last week from the FDA, will now head into Phase ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... now consolidated as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in ... number of custodial files the PSC may receive for corporate employees involved in ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... finds , , WEDNESDAY, Nov. 19 (HealthDay News) -- ... is roughly the same no matter what the patient,s ... disparities in our health care system have been well ... artery disease, congestive heart failure, renal failure, acute appendicitis ...
... Rendell today revised his July 8 executive order extending the ... Under the revised order, the council will remain in operation ... the council, whichever occurs first. , ... PHC4 was allowed to "sunset" by the General Assembly. It ...
... Educate Health Care Stakeholders , ... The Virginia Business Coalition on Health (VBCH) announced its ... efforts initiated by the Center for Medicare and Medicaid ... Events" - serious and costly preventable hospital errors. Effective ...
... Leaves Skin Consistently Smooth and Visibly Tight , ... Body-sculpting technology with consistently smooth, visibly tight results ... now available to those who want effective body reshaping ... leader in aesthetic body shaping technology, SmoothLipo is a ...
... Nov. 19 (HealthDay News) -- The dietary supplement beta-alanine ... -- improves muscle endurance in the elderly, according to ... the prevention of falls, and the maintenance of health ... study author Jeffrey Stout of the University of Oklahoma. ...
... Researchers at Southern Methodist University in Dallas are pioneering ... scan data from Persian Gulf War veterans, aiming to ... Gulf War Syndrome. , Richard Gunst, Wayne Woodward and ... collaborating with imaging specialists at UT Southwestern Medical Center ...
Cached Medicine News:Health News:Patient's Race Doesn't Affect Emergency Room Care 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 3Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 2Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 3Health News:Eleme Medical Launches SmoothLipo(TM) Body Shaping Treatment 2Health News:Deep brain mapping to isolate evidence of Gulf War syndrome 2
... ICP Monitoring System provides ... intracranial pressure at the ... levels. The information is ... through a hydrostatic column ...
The Optical Tracking System provides a complete solution for image-guided surgery. Precision tracking technology converges with powerful visualization software for optimal surgical planning and navig...
Penfield Dissector #2...
ScalpFix scalp clip system includes an reusable handle, scalp clips, sterile packed cartridges and removal forceps. It is easy to use, time saving and fast application....
Medicine Products: